Skip to main navigation Skip to search Skip to main content

The diagnosis of dioxin-associated illness

  • St. Louis University School of Medicine
  • New York University School of Medicine

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

The clinical recognition of dioxin-associated illness can be extremely difficult for the physician. After analyzing the relative sensitivity and specificity of reported manifestations of exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD), we suggest criteria for the diagnosis of dioxin toxicity. Exposure to higher doses of 2,3,7,8-TCDD may lead to the appearance of chloracne and the increased excretion of porphyrins and porphyria cutanea tarda. Liver function abnormalities, peripheral neuropathy, hyperlipidemia, and evidence of weakness and depression may occur following exposure; however, these findings are less specific since diseases such as diabetes or alcoholism could cause several of these problems. The long-term effects of exposure to low-dose TCDD are currently uncertain.
Original languageEnglish
Pages (from-to)103-108
Number of pages6
JournalAmerican Journal of Preventive Medicine
Volume2
Issue number2
DOIs
StatePublished - 1986

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Scopus Subject Areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'The diagnosis of dioxin-associated illness'. Together they form a unique fingerprint.

Cite this